Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance

Since emergence of SARS-CoV-2 in late 2019, there has been a critical need to understand prevalence, transmission patterns, to calculate the burden of disease and case fatality rates. Molecular diagnostics, the gold standard for identifying viremic cases, are not ideal for determining true case coun...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Brandi, Lester, Sandra, Mills, Lisa, Rasheed, Mohammad Ata Ur, Moye, Stefany, Abiona, Olubukola, Hutchinson, Geoffrey B., Morales-Betoulle, Maria, Krapinunaya, Inna, Gibbons, Ardith, Chiang, Cheng-Feng, Cannon, Deborah, Klena, John, Johnson, Jeffrey A., Owen, Sherry Michele, Graham, Barney S., Corbett, Kizzmekia S., Thornburg, Natalie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239067/
https://www.ncbi.nlm.nih.gov/pubmed/32511332
http://dx.doi.org/10.1101/2020.04.24.057323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239067/
https://www.ncbi.nlm.nih.gov/pubmed/32511332
http://dx.doi.org/10.1101/2020.04.24.057323

Ejemplares similares